🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsTRIUMPH program trial design overview — all Phase 3 arms Page 6

TRIUMPH program trial design overview — all Phase 3 arms

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 324 replies 45,778 viewsPage 6 of 20
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Mar 27, 2024 at 3:12 PM#26
LabKate said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

46 21Dr.SportsMedIN, amy_econ_NJ, bbq_ray_KC and 43 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Mar 31, 2024 at 7:00 AM#27
LabKate said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Thank you — that is the clearest version of this I have read, and I have read a lot of them. I will report back once I have actually tried it.

45 20TomTeleRx, DoseLogDan, SleepFixSam and 42 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Apr 3, 2024 at 10:46 PM#28

Clinical perspective, offered as context rather than as advice. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

44 19tommy_boulder, hyun_seoul, jim_asheville and 41 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Apr 7, 2024 at 2:30 PM#29
DeniseRN_TPA said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

Same experience, arrived at from the opposite direction. The detail I would add is minor and it is already implied above.

Last edited: Apr 7, 2024 at 6:30 PM
43 18LeilaHI, marcus_mpls, DeniseRN_TPA and 40 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Apr 11, 2024 at 6:12 AM#30

OP back with an update, since a thread like this is useless without one.

Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have. That was reassuring rather than otherwise.

Last edited: Apr 11, 2024 at 11:12 AM
21 21lori_vegas, Dr.PulmRoch, maya_sedona and 18 others
Reply Quote Save Share Report
14567820

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register